Clin Mol Hepatol > Accepted Articles
EXAMINING THE THERAPEUTIC LANDSCAPE OF BETA-BLOCKERS IN PORTAL HYPERTENSION
Anna Brujats1, Càndid Villanueva1,2
1Hospital de la Santa Creu i Sant Pau. Biomedical Research Institute Sant Pau (IIB Sant Pau). 08025 Barcelona. Universitat Autònoma de Barcelona
2Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)
Correspondence :  Càndid Villanueva ,
Tel: 34 93 5565920, Fax: 34 93 556 5608, Email: cvillanueva@santpau.cat
Received: February 24, 2024  Revised: March 4, 2024   Accepted: March 4, 2024
KeyWords: Clinically significant portal hypertension; β-blockers; Prevention of decompensation of cirrhosis
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 425 View
  • 19 Download
Related articles

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 415
TOTAL : 1797585
Close layer